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The Bernard and Joan Marshal Awards are a tradition introduced in 2010 at the British 
Society for Cardiovascular Research, Autumn Science Meeting. They have been a 
huge success and were designed to award both our young up-and-coming 
researchers as well as established researchers, with distinguished contributions.  
 
Dr Marwa Mahmoud, a rising star in 
Cardiovascular Science, received the 
Young Investigator Award, 2018. Dr 
Mahmoud completed her PhD studied in 
the laboratory of Prof Paul Evans, where 
she investigated the contribution of 
Twist1/GATA4 in endothelial cells 
exposed to shear stress. She won the 
award giving KHU WDON HQWLWOHG µTWIST1 
Integrates Endothelial Responses to 
Flow in Vascular Dysfunction and 
Atherosclerosis¶ and talked to us about 
her work in a clear and concise manner exhibiting understanding of her area that is 
exceptional. She is pictured here receiving yet another award, while a PhD student, 
together with her supervisor Prof Paul C Evans. Dr Mahmoud studied and expression 
and function of the transcription factor Twist1 in endothelial cells during the initiation 
of atherosclerosis, using culture cells and mouse models. She found that Twist1 is 
expressed preferentially at low shear stress regions in vivo and in vitro, and that 
inhibition of twist1 led to reduced proliferation and inflammation and a reduction in 
atherosclerosis and vascular leakiness. These observations point to Twist1 as an 
important driver of endothelial pathophysiology and atherosclerosis at sites of 
disturbed blood flow. Her work was published in Circulation Research in 2016 
(Mahmoud, Kim et al., 2016). Dr Mahmoud is now based in New York in the laboratory 
of Professor John Tarbell who is a leader in the field of endothelial mechanosensing. 
Before moving to New York, she took a post-doctoral position in the laboratory of 
Professor Hanjoong Jo (Atlanta, USA) who co-incidentally was our Marshall 
Distinguished Investigator!  
 
Our other four young investigator presenters, which were selected from abstracts 
submission were: Scott Chiesa (University College London), Tom Kaiser .LQJ¶V
College London) and Filippo Perbellini (Imperial College London) and Sophie 
Saxton (University of Manchester). They each gave excellent lectures and shared 
important findings in cardiovascular research.  
 Scott Chiesa has studied the function of high-density lipoproteins, which are widely 
thought to have anti-atherogenic effects in patients with type I diabetes and healthy 
controls. Fascinatingly, Dr Chiesa observed that the function of HDL is switched from 
protective to pathogenic in patients with type I diabetes since it had reduced ability to 
induce protective NO in endothelial cells and enhanced ability to induce 
proatherogenic superoxide. It was concluded that HDL is not simply a protective 
molecule and that its function is altered in patients with type I diabetes. 
 
Tom Kaier presented his studies of cardiac myosin-binding protein C (cMyC) as a 
marker for the early diagnosis of acute myocardial infarction which were published in 
Circulation in 2017 (Kaier, Twerenbold et al., 2017). His painstaking studies of almost 
2000 patients presenting to the emergency room revealed that diagnostic accuracy of 
cMyC for acute myocardial infarction was similar to high-sensitivity cardiac troponin I 
(the current gold standard marker) for the entire cohort, but cMyC was superior for so-
called early presenters with chest pain for less than 3 hours. This means that cMyC 
testing may allow early triaging and discharge of low risk patients, which has high 
clinical and financial impact given the millions of patients that attend emergency rooms 
with chest pain each year. 
 
Filippo Perbellini presented pioneering work looking at the ability of 
electromechanical stimulation to improve the maintenance of cardiac phenotype in 
cultured myocardial slices. He described conditions that allowed slices of heart to 
retain contractility in culture for extended periods, an exciting observation that is a step 
towards being able to develop a stable in vitro model of cardiac tissue which would 
have many important uses including testing of pharmacological agents. 
 
Sophie Saxton presented her research into perivascular adipose tissue (PVAT) which 
plays a major role in controlling vascular tone by exerting an anti-contractile effect. 
She looked at the factors that can influence the function of perivascular adipose tissue 
using a mouse model and found that obesity reduced the anti-contractile effects of 
PVAT but exercise was able to reverse PVAT dysfunction. The conclusion has 
important implications for the use of exercise to counteract the vascular-damaging 
effects of obesity. 
Professor Hanjoong Jo received the Bernard 
and Joan Marshal distinguished investigator 
award!  The Bernard and Joan Marshal 
Distinguished Investigator award is presented to a 
researcher who has made substantial contributions 
to cardiovascular research over many years. The 
distinguished investigator is nominated by the 
British Society for Cardiovascular Research 
committee members, receives an honorarium and 
presents the Marshall Lecture. 
 
In the 2018 Autumn meeting, the Marshall 
Distinguished Investigator was Professor Hanjoong 
Jo, PhD, from the Coulter Department of Biomedical Engineering and the Division of 
Cardiology, Emory University and Georgia Institute of Technology, Atlanta, USA. After 
completing a first degree in animal science in Korea, Professor Jo moved to 
Pennsylvania State University, USA to study for a PhD under the co-mentorship of 
John Tarbell who is one of the founding fathers of the vascular biomechanics field and 
Theodore Hollis, a respected vascular physiologist. And for his PhD, Professor Jo 
worked on the effects of mechanical forces on endothelial cell behaviour and this 
initiated a life-long interest in this subject. He then moved to Washington University in 
St. Louis and University of Alabama in Birmingham (UAB)for a Post-doctoral training 
in Professor -D\ 0F'RQDOG¶V ODE DQG LW ZDV WKHUH WKDW KH EHFDPH LQWHUHVWHG LQ
intracellular signalling mechanisms. And when Professor Jo started his own lab at UAB 
a few years later, he decided to combine his two interests by studying the effects of 
mechanical forces on signalling pathways - and during this time he published some 
classical papers on MAP kinases and eNOS regulation by flow(Go, Boo et al., 2001, 
Go, Levonen et al., 2001, Go, Park et al., 1998, Go, Patel et al., 1999, Park, Go et al., 
2000, Park, Go et al., 1998). In 2000, Professor Jo moved to Emory/Georgia Tech 
firstly as an associate professor and then in 2007 as the Ada Lee and Pete Correll 
Professor in Biomedical Engineering (BME). In 2013, he became the John and John 
Portman Professor and Associate Chair of Emory BME. And at Emory, Professor Jo 
has built a laboratory that is world-leading in the field of vascular mechanobiology - 
his lab has developed several models of vascular shear responses that are used all 
over the world, and he has pioneered the use of systems biology approaches to define 
the networks of genes and non-coding RNAs that control vascular responses to 
mechanical force. 3URIHVVRU-R¶V work has been published in the highest journals, he 
has a h-index of 62 and his papers have received more than 13,000 citations so for all 
these reasons he is a worthy recipient of the Bernard and Joan Marshal distinguished 
investigator award! 
 
It is notable that Professor Jo devoted most of his lecture describing new, unpublished 
data, which testifies to the dynamic nature of his laboratory. In particular, he described 
a new protective pathway against aortic valve calcification activated by laminar flow in 
endothelial cells that involves induction of microRNA483. 3URIHVVRU-R¶VSUHVHQWDWLRQ
was a highlight of the meeting that generated a great deal of discussion and we look 
forward to hearing more on the role of the mechanosensitive miR483 in aortic valve 
calcification in the future. 
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